DIVERSIFIED HEALTHCARE TRUST: 10-Q filed 2017-08-03
What DIVERSIFIED HEALTHCARE TRUST reported in its quarterly report filed 2017-08-03 (fiscal Q2 2017): 24 published measures, 70 facts as tagged in accession 0001075415-17-000021.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-08-03
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001075415-17-000021 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DIVERSIFIED HEALTHCARE TRUST filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 7,183,620,000 | USD | |
| At 2016-12-31 | 7,227,754,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 3,842,841,000 | USD | |
| At 2016-12-31 | 4,028,349,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 3,160,917,000 | USD | |
| At 2016-12-31 | 3,199,405,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 27,160,000 | USD | |
| At 2016-12-31 | 31,749,000 | USD | |
| At 2016-06-30 | 25,633,000 | USD | |
| At 2015-12-31 | 37,656,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 16,042,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 48,197,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 39,233,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 70,507,000 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 201,550,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 216,171,000 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 265,013,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 529,574,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 261,367,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 519,742,000 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | -133,926,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | -1,666,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | -72,213,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | -226,528,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 1,667,082,000 | USD | |
| At 2016-12-31 | 1,618,885,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 237,399,000 | shares | 91 |
| 2017-01-01 to 2017-06-30 | 237,395,000 | shares | 181 |
| 2016-04-01 to 2016-06-30 | 237,325,000 | shares | 91 |
| 2016-01-01 to 2016-06-30 | 237,320,000 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 237,445,000 | shares | 91 |
| 2017-01-01 to 2017-06-30 | 237,433,000 | shares | 181 |
| 2016-04-01 to 2016-06-30 | 237,363,000 | shares | 91 |
| 2016-01-01 to 2016-06-30 | 237,349,000 | shares | 182 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 99,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 191,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 108,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 202,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 64,545,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 139,500,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 75,415,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 145,928,000 | USD | 182 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 40,800,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 84,289,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 41,118,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 80,399,000 | USD | 182 |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 476,494,000 | USD | |
| At 2016-12-31 | 514,446,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 11,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 0 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 237,558,963 | shares | |
| At 2016-12-31 | 237,544,479 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 58,861,000 | USD | |
| At 2016-12-31 | 34,549,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 3,340,779,000 | USD | |
| At 2016-12-31 | 3,199,405,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 16,187,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 72,509,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 55,207,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 110,720,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 22,922,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 38,005,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 11,965,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 22,828,000 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 142,844,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 142,594,000 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 69,669,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 142,844,000 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 71,372,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 142,594,000 | USD | 182 |
Inspect the source
- Entity
- DIVERSIFIED HEALTHCARE TRUST / CIK 0001075415
- Captured
- 2026-09-20T05:20:10.749Z
- SEC response SHA-256
8898f1539f403516574ac52f0720ed5518196148c88e53b7d3b2e881631ea620
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001075415.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))